Applied DNA Sciences (APDN) Tops Q2 EPS by 10c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- S&P 500 ends higher as traders shift from AI to healthcare
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
Tweet
Share
E-mailGet Alerts APDN Hot Sheet
Price: $5.62 --0%
Financial Fact:
Depreciation and amortization: 148.53K
Today's EPS Names:
QEPC, NTRP, LOOP, More
Financial Fact:
Depreciation and amortization: 148.53K
Today's EPS Names:
QEPC, NTRP, LOOP, More
Join SI Premium – FREE
Applied DNA Sciences (NASDAQ: APDN) reported Q2 EPS of ($0.23), $0.10 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $6.1 million versus the consensus estimate of $4.5 million.
For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AIR Global sets first-ever dividend, $100M buyback amid business, cash strength
- FMC tumbles 35% after slashing Q3 outlook over weak demand and inventory issues
- Prologis (PLD) Tops Q3 EPS by 8c; revises guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
